在伊朗实施的一项基于社区药房的心血管疾病风险筛查服务。

A community pharmacy-based cardiovascular risk screening service implemented in Iran.

作者信息

Jahangard-Rafsanjani Zahra, Hakimzadeh Negar, Sarayani Amir, Najafi Sheyda, Heidari Kazem, Javadi Mohammad R, Hadjibabaie Molouk, Gholami Kheirollah

机构信息

Assistant Professor of Clinical Pharmacy. Department of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences. Tehran (Iran).

PharmD. Faculty of Pharmacy, Tehran University of Medical Sciences. Tehran (Iran).

出版信息

Pharm Pract (Granada). 2017 Apr-Jun;15(2):919. doi: 10.18549/PharmPract.2017.02.919. Epub 2017 Jun 30.

Abstract

BACKGROUND

Cardiovascular disease is a major health concern around the world.

OBJECTIVE

To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran.

METHODS

A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded.

RESULTS

Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician.

CONCLUSION

A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.

摘要

背景

心血管疾病是全球主要的健康问题。

目的

评估伊朗一家城市转诊社区药房基于药房的心血管筛查的结果和可行性。

方法

在一家转诊社区药房进行了一项横断面研究。对年龄在30至75岁之间、既往未被诊断患有心血管疾病或糖尿病的受试者进行筛查。调查了所有主要心血管危险因素、运动习惯、医疗状况、用药情况和家族史。计算弗雷明汉风险评分,高危个体被给予一份由临床药剂师签署的临床总结表,并被鼓励去看医生进行随访。在招募期结束后一个月联系受试者,并记录他们对随访建议的依从性。

结果

分析了287名参与者的数据,其中146人因至少一项实验室检查异常而被转诊。结果显示,26例患者心血管疾病风险大于20%,32例收缩压高,22例舒张压高,50例总胆固醇水平高,108例高密度脂蛋白胆固醇水平低,22例血糖异常。大约一半收到随访建议的个体预约了医生。总体而言,15.9%的个体接受了药物治疗,15.9%的个体接受了关于危险因素调整的适当建议。此外,7.5%的个体正在接受医生评估。

结论

社区药房的筛查项目有可能识别出心血管危险因素升高的患者。需要制定一项提高患者对随访建议依从性的计划。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索